Insider filing · HALO
Mahesh Krishnan
Director
profile →
Halozyme Therapeutics, Inc.
HALO · Healthcare · 39 filings in 24 months
ticker →
Mahesh Krishnan sold $548K of Halozyme Therapeutics (HALO)
Executed Jun 29, disclosed Jun 30, 1 day later.
Value, as filed
$548K
7,304 sh × $75.00
Executed
Jun 29
the trade date, as filed
Disclosed
Jun 30
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
MKMahesh Krishnan (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Halozyme Therapeutics, Inc. (HALO). The largest single filing was $548K of HALO (7,304 sh × $75.00, as filed), executed Jun 29.
The name
HALOHealthcare · Halozyme Therapeutics, Inc., a biopharmaceutical company, researches, develops, and commercializes of proprietary enzymes and devices in th…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→